Navigation Links
Aptel Research Launches Unique Patient-centric Syndicated Report Series That Analyze the Patient Journey for Chronic Diseases in Specialty Markets
Date:9/16/2013

CAMBRIDGE, Mass., Sept. 16, 2013 /PRNewswire/ -- Aptel Research, a specialty marketing research and consulting company that provides actionable strategic insights to the pharmaceutical and biotech industries, today launched Patient Voices Syndicated Report Series™. Patient Voices Syndicated Report Series provides rich insights into the emotional and rational factors that impact the patient journey through specific chronic diseases in specialty markets. The first report covers multiple sclerosis in the United States. Future reports will cover other chronic diseases in the U.S. and in international markets. Each report captures the various aspects of the patient journey from symptoms to diagnosis to treatment, and identifies issues and gaps along the way. The reports employ a mix of qualitative interviews, quantitative surveys, and an analysis of patient social media to create a nuanced understanding of patients' experiences, as well as brand attitudes and unmet needs.

"Patients with relapsing forms of MS are fortunate to have many treatment options now, including oral treatments," said Aptel Research CEO Michele Derai. "The MS landscape is rapidly changing and additional multiple sclerosis agents are in various stages of development in the U.S. and abroad. The Patient Voices Syndicated Report Series will serve the product life-cycle needs of our clients by allowing them to differentiate their products to best match patients' lives and mindsets at any point in their journey. The insights provided by the Patient Voices Syndicated Report Series will enable our clients to uncover new marketing opportunities."

With decades of experience, in-depth business and scientific expertise and a global network, Aptel Research offers customized strategic market research from market assessment to branding strategy with key target audiences, including key opinion leaders.

For more information visit Aptel Research.

Media contact:  Jane A. Kramer 781-799-9524


'/>"/>
SOURCE Aptel Research
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging - Focus on Contract Packaging
2. GSK research estimates significantly higher rates of pertussis among older adults than now reported
3. CVS Caremark Research Finds New, More Accurate Method for Classifying Patient Medication Adherence Behaviors
4. BGI Tech and South Texas Accelerated Research Therapeutics Initiate Collaboration to Advance Unique San Antonio 1000 Cancer Genome Project
5. Seahorse XF Technology Helps P&G Research the Science of Skin
6. Pharmaceutical Giants Back Researchers in Unique US Competition
7. Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm
8. MPI Research Breaks Ground On New World-Class Imaging Center
9. New Workflow to Provide Scientists with Tools That Enable Single Cell Analysis for Oncology, Immunology and Stem Cell Research
10. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
11. ResearchMoz.us: Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):